Tall Cell Variant Thyroid Gland Papillary Carcinoma
specificA morphologic variant of papillary carcinoma of the thyroid gland characterized by the presence of tall malignant follicular cells, arranged in papillary and trabecular patterns. Necrotic changes and high mitotic activity are present.
13
Centers
10
Active Trials
—
Cancer Funding
Top Centers for Tall Cell Variant Thyroid Gland Papillary Carcinoma(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 59.0 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 59.0 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 59.0 |
| 4 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 59.0 |
| 5 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 59.0 |
| 6 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 59.0 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 59.0 |
| 8 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program | 59.0 |
| 9 | Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program | 59.0 |
| 10 | Active Research Program | 59.0 |
| 11 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 36.5 |
| 12 | University of Illinois Cancer CenterChicago, IL | 36.5 |
| 13 | Boston University Cancer CenterBoston, MA | 36.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →